Mar 20 |
Beyond Air rises after pricing its $16M direct offering
|
Mar 20 |
Beyond Air® Announces Pricing of $16.0 Million Registered Direct Offering of Common Stock and Warrants
|
Feb 13 |
Beyond Air, Inc. (XAIR) Q3 2024 Earnings Call Transcript
|
Feb 12 |
Beyond Air GAAP EPS of -$0.50 beats by $0.04, revenue of $0.4M misses by $0.05M
|
Feb 12 |
Recap: Beyond Air Q3 Earnings
|
Feb 12 |
Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2024
|
Jan 18 |
Beyond Air® Schedules Third Fiscal Quarter 2024 Financial Results Conference Call and Webcast
|
Dec 27 |
Beyond Cancer™ Phase 1 Study Clears Cohort 1 in Patients with Advanced Relapsed or Refractory Unresectable Primary or Metastatic Cutaneous or Subcutaneous Solid Tumors
|
Dec 23 |
Beyond Air Independent Director Acquires 102% More Stock
|
Dec 21 |
Insider Buying: CEO Steven Lisi Acquires 77,775 Shares of Beyond Air Inc
|